He, R., & Zhang, Z. (2022). Rad53 arrests leading and lagging strand DNA synthesis via distinct mechanisms in response to DNA replication stress. BioEssays, 44(9). Portico. https://doi.org/10.1002/bies.202200061

Kinslow, C. J., Kim, A., Sanchez, G. I., Cheng, S. K., Kachnic, L. A., Neugut, A. I., & Horowitz, D. P. (2022). Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018. JAMA Oncology, 8(9), 1354. https://doi.org/10.1001/jamaoncol.2022.2624

Fu, J., Wang, Z., Martinez, M., Jiao, W., Frangaj, K., Jones, R., Guo, X. V., Zhang, Y., Kuo, W.-I., Obradovic, A., Ma, W., Rogers, K., Kato, T., Shen, Y., & Sykes, M. (2022). 425.3: Single-Cell Immune Profiling of Human Intestinal Allografts Reveals Differential Phenotypes of Alloreactive T-Cell Clones in Quiescent vs Chronically Rejecting Allografts. Transplantation, 106(9S), S485–S485. https://doi.org/10.1097/01.tp.0000888048.23424.42

Dimitriou, F., Hassel, J. C., Orloff, M., Hughes, I., Kapiteijn, E., Mehmi, I., Montazeri, K., Johnson, D. B., Grover, P., Gerard, C. L., Simeone, E., Gaudy Marqueste, C., Cheng, P., Long, G. V., Carvajal, R. D., & Dummer, R. (2022). 832P Treatment sequence with tebentafusp (tebe) and anti-PD1/ipilimumab (PD1+IPI) in HLA-A2*02:01 patients (pts) with metastatic uveal melanoma (mUM). Annals of Oncology, 33, S929. https://doi.org/10.1016/j.annonc.2022.07.958

Gao, X., Shen, W., Ning, J., Feng, Z., & Hu, J. (2021). Addressing patient heterogeneity in disease predictive model development. Biometrics, 78(3), 1045–1055. Portico. https://doi.org/10.1111/biom.13514

Zenilman, A., Fan, W., Hernan, R., Wynn, J., Abramov, A., Farkouh-Karoleski, C., Aspelund, G., Krishnan, U. S., Khlevner, J., Azarow, K., Crombleholme, T., Cusick, R., Chung, D., Danko, M. E., Potoka, D., Lim, F. Y., McCulley, D. J., Mychaliska, G. B., Schindel, D., … Duron, V. P. (2022). Being small for gestational age is not an independent risk factor for mortality in neonates with congenital diaphragmatic hernia: a multicenter study. Journal of Perinatology, 42(9), 1183–1188. https://doi.org/10.1038/s41372-022-01326-4

Bunevicius, A., Donovan, L., & Sheehan, J. (2022). Health related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review. Journal of Neuro-Oncology, 159(2), 319–331. https://doi.org/10.1007/s11060-022-04067-8

Wright, J. D., Chen, L., Melamed, A., Clair, C. M. St., Hou, J. Y., Khoury-Collado, F., Gockley, A., Accordino, M., Hershman, D. L., & Xu, X. (2022). Containment Bag Use Among Women Who Undergo Hysterectomy With Laparoscopic Power Morcellation. Obstetrics & Gynecology, 140(3), 371–380. https://doi.org/10.1097/aog.0000000000004886

Laise, P., Bosker, G., Califano, A., & Alvarez, M. J. (2022). A Patient‐to‐Model‐to‐Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture. Current Protocols, 2(9). Portico. https://doi.org/10.1002/cpz1.544

Mojahed, D., Applegate, M. B., Guo, H., Taback, B., Ha, R., Hibshoosh, H., & Hendon, C. P. (2022). Optical coherence tomography holds promise to transform the diagnostic anatomic pathology gross evaluation process. Journal of Biomedical Optics, 27(09). https://doi.org/10.1117/1.jbo.27.9.096003

Hopson, M. B., Bhutani, D., Sarkaria, S., Maurer, M. S., Griffin, J. M., Mapara, M., Lentzsch, S., & Chakraborty, R. (2022). Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis. Leukemia & Lymphoma, 63(9), 2109–2113. https://doi.org/10.1080/10428194.2022.2060502

Khan, S., Lutzky, J., Shoushtari, A. N., Jeter, J., Marr, B., Olencki, T. E., Cebulla, C. M., Abdel-Rahman, M., Harbour, J. W., Sender, N., Nesson, A., Singh-Kandah, S., Hernandez, S., King, J., Katari, M. S., Dimapanat, L., Izard, S., Ambrosini, G., Surriga, O., … Carvajal, R. D. (2022). Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.976837

Seymour, J. F., Kipps, T. J., Eichhorst, B. F., D’Rozario, J., Owen, C. J., Assouline, S., Lamanna, N., Robak, T., de la Serna, J., Jaeger, U., Cartron, G., Montillo, M., Mellink, C., Chyla, B., Panchal, A., Lu, T., Wu, J. Q., Jiang, Y., Lefebure, M., … Kater, A. P. (2022). Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab. Blood, 140(8), 839–850. https://doi.org/10.1182/blood.2021015014

Clement, C. C., Osan, J., Buque, A., Nanaware, P. P., Chang, Y.-C., Perino, G., Shetty, M., Yamazaki, T., Tsai, W. L., Urbanska, A. M., Calvo-Calle, J. M., Ramsamooj, S., Ramsamooj, S., Vergani, D., Mieli-Vergani, G., Terziroli Beretta-Piccoli, B., Gadina, M., Montagna, C., Goncalves, M. D., … Santambrogio, L. (2022). PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes. Science Immunology, 7(74). https://doi.org/10.1126/sciimmunol.abl3795

He, D., Feng, H., Sundberg, B., Yang, J., Powers, J., Christian, A. H., Wilkinson, J. E., Monnin, C., Avizonis, D., Thomas, C. J., Friedman, R. A., Kluger, M. D., Hollingsworth, M. A., Grandgenett, P. M., Klute, K. A., Toste, F. D., Chang, C. J., & Chio, I. I. C. (2022). Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Molecular Cell, 82(16), 3045-3060.e11. https://doi.org/10.1016/j.molcel.2022.06.005

Liu, Y., Liu, Y., Ye, S., Feng, H., & Ma, L. (2022). Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.985484

Halder, S., Ranjha, L., Taglialatela, A., Ciccia, A., & Cejka, P. (2022). Strand annealing and motor driven activities of SMARCAL1 and ZRANB3 are stimulated by RAD51 and the paralog complex. Nucleic Acids Research, 50(14), 8008–8022. https://doi.org/10.1093/nar/gkac583

Lassman, A. B., Hoang-Xuan, K., Polley, M.-Y. C., Brandes, A. A., Cairncross, J. G., Kros, J. M., Ashby, L. S., Taphoorn, M. J. B., Souhami, L., Dinjens, W. N. M., Laack, N. N., Kouwenhoven, M. C. M., Fink, K. L., French, P. J., Macdonald, D. R., Lacombe, D., Won, M., Gorlia, T., Mehta, M. P., & van den Bent, M. J. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. Journal of Clinical Oncology, 40(23), 2539–2545. https://doi.org/10.1200/jco.21.02543

Palmerola, K. L., Amrane, S., De Los Angeles, A., Xu, S., Wang, N., de Pinho, J., Zuccaro, M. V., Taglialatela, A., Massey, D. J., Turocy, J., Robles, A., Subbiah, A., Prosser, B., Lobo, R., Ciccia, A., Koren, A., Baslan, T., & Egli, D. (2022). Replication stress impairs chromosome segregation and preimplantation development in human embryos. Cell, 185(16), 2988-3007.e20. https://doi.org/10.1016/j.cell.2022.06.028

Moore, E. K., Strazza, M., & Mor, A. (2022). Combination Approaches to Target PD-1 Signaling in Cancer. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.927265

Gartrell, R. D., Blake, Z., Rizk, E. M., Perez-Lorenzo, R., Weisberg, S. P., Simoes, I., Esancy, C., Fu, Y., Davari, D. R., Barker, L., Finkel, G., Mondal, M., Minns, H. E., Wang, S. W., Fullerton, B. T., Lozano, F., Chiuzan, C., Horst, B., & Saenger, Y. M. (2022). Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma. Cancer Immunology, Immunotherapy, 71(8), 1837–1849. https://doi.org/10.1007/s00262-021-03088-y

Harimoto, T., Hahn, J., Chen, Y.-Y., Im, J., Zhang, J., Hou, N., Li, F., Coker, C., Gray, K., Harr, N., Chowdhury, S., Pu, K., Nimura, C., Arpaia, N., Leong, K. W., & Danino, T. (2022). A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nature Biotechnology, 40(8), 1259–1269. https://doi.org/10.1038/s41587-022-01244-y

Laszkowska, M., Truong, H., Faye, A. S., Kim, J., Tan, S. X., Lim, F., Abrams, J. A., & Hur, C. (2021). Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer. Digestive Diseases and Sciences, 67(8), 3693–3701. https://doi.org/10.1007/s10620-021-07276-9

Vanguri, R. S., Fenn, K. M., Kearney, M. R., Wang, Q., Guo, H., Marks, D. K., Chin, C., Alcus, C. F., Thompson, J. B., Leu, C.-S., Hibshoosh, H., Kalinsky, K. M., Mathews, J. C., Nadeem, S., Hollmann, T. J., & Connolly, E. P. (2022). Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer. Clinical Breast Cancer, 22(6), 538–546. https://doi.org/10.1016/j.clbc.2022.04.002

Karia, P. S., Huang, Y., Tehranifar, P., Visvanathan, K., Wright, J. D., & Genkinger, J. M. (2022). Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States. American Journal of Obstetrics and Gynecology, 227(2), 257.e1-257.e22. https://doi.org/10.1016/j.ajog.2022.04.036

Diggs, A., Sia, T. Y., Huang, Y., Gockley, A., Melamed, A., Khoury-Collado, F., St. Clair, C., Hou, J. Y., Hershman, D. L., & Wright, J. D. (2022). Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma. Gynecologic Oncology, 166(2), 308–316. https://doi.org/10.1016/j.ygyno.2022.05.018

Zhang, X., Wang, B. Z., Kim, M., Nash, T. R., Liu, B., Rao, J., Lock, R., Tamargo, M., Soni, R. K., Belov, J., Li, E., Vunjak-Novakovic, G., & Fine, B. (2022). STK25 inhibits PKA signaling by phosphorylating PRKAR1A. Cell Reports, 40(7), 111203. https://doi.org/10.1016/j.celrep.2022.111203

Zeinomar, N., Grant-Alfieri, A., Burke, K. R., de Hoz, M., Tehranifar, P., Walker, D. A. H., Morton, T., Shepard, P., Herbstman, J. B., Miller, R. L., Perera, F., & Terry, M. B. (2021). Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool. Journal of Cancer Education, 37(4), 1220–1227. https://doi.org/10.1007/s13187-020-01943-7

Geczik, A. M., Ferris, J. S., Terry, M. B., Andrulis, I. L., Buys, S. S., Daly, M. B., Hopper, J. L., John, E. M., Kurian, A. W., Southey, M. C., Liao, Y., & Genkinger, J. M. (2022). Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations. Breast Cancer Research and Treatment, 194(3), 673–682. https://doi.org/10.1007/s10549-022-06656-7

Ellingson, B. M., Gerstner, E. R., Lassman, A. B., Chung, C., Colman, H., Cole, P. E., Leung, D., Allen, J. E., Ahluwalia, M. S., Boxerman, J., Brown, M., Goldin, J., Nduom, E., Hassan, I., Gilbert, M. R., Mellinghoff, I. K., Weller, M., Chang, S., Arons, D., … Cloughesy, T. F. (2022). Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. Neuro-Oncology, 24(8), 1219–1229. https://doi.org/10.1093/neuonc/noac086

Bal, E., Kumar, R., Hadigol, M., Holmes, A. B., Hilton, L. K., Loh, J. W., Dreval, K., Wong, J. C. H., Vlasevska, S., Corinaldesi, C., Soni, R. K., Basso, K., Morin, R. D., Khiabanian, H., Pasqualucci, L., & Dalla-Favera, R. (2022). Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature, 607(7920), 808–815. https://doi.org/10.1038/s41586-022-04906-8

Scales, M. K., Velez-Delgado, A., Steele, N. G., Schrader, H. E., Stabnick, A. M., Yan, W., Mercado Soto, N. M., Nwosu, Z. C., Johnson, C., Zhang, Y., Salas-Escabillas, D. J., Menjivar, R. E., Maurer, H. C., Crawford, H. C., Bednar, F., Olive, K. P., Pasca di Magliano, M., & Allen, B. L. (2022). Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. PLOS Genetics, 18(7), e1010315. https://doi.org/10.1371/journal.pgen.1010315

Liao, L., Chen, L., Gockley, A., Melamed, A., St Clair, C. M., Hou, J. Y., Khoury-Collado, F., Accordino, M., Hershman, D. L., & Wright, J. D. (2022). Temporal Trends in Cervical Cancer Screening Practices and Associated Downstream Abnormalities and Procedures Among Women With Insurance in the United States. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000004838

Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022). Understanding the cellular interactome of non-alcoholic fatty liver disease. JHEP Reports, 4(8), 100524. https://doi.org/10.1016/j.jhepr.2022.100524

Llanos, A. A. M., Aremu, J. B., Cheng, T.-Y. D., Chen, W., Chekmareva, M. A., Cespedes Feliciano, E. M., Qin, B., Lin, Y., Omene, C., Khoury, T., Hong, C.-C., Yao, S., Ambrosone, C. B., Bandera, E. V., & Demissie, K. (2022). Greater Body Fatness Is Associated With Higher Protein Expression of LEPR in Breast Tumor Tissues: A Cross-Sectional Analysis in the Women’s Circle of Health Study. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.879164

Kukafka, R., Pan, S., Silverman, T., Zhang, T., Chung, W. K., Terry, M. B., Fleck, E., Younge, R. G., Trivedi, M. S., McGuinness, J. E., He, T., Dimond, J., & Crew, K. D. (2022). Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care. JAMA Network Open, 5(7), e2222092. https://doi.org/10.1001/jamanetworkopen.2022.22092

Ayeni, O. A., O’Neil, D. S., Pumpalova, Y. S., Chen, W. C., Nietz, S., Phakathi, B., Buccimazza, I., Čačala, S., Stopforth, L. W., Farrow, H. A., Mapanga, W., Joffe, M., Chirwa, T., McCormack, V., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., & Cubasch, H. (2022). Impact of HIV infection on survival among women with stage I‐III breast cancer: Results from the South African breast cancer and HIV outcomes study. International Journal of Cancer, 151(2), 209–221. Portico. https://doi.org/10.1002/ijc.33981

Beauchemin, M. P., Raghunathan, R. R., Accordino, M. K., Cogan, J. C., Kahn, J. M., Wright, J. D., & Hershman, D. L. (2022). New persistent opioid use among adolescents and young adults with sarcoma. Cancer, 128(14), 2777–2785. Portico. https://doi.org/10.1002/cncr.34238

Papachristodoulou, A., & Abate-Shen, C. (2022). Precision intervention for prostate cancer: Re-evaluating who is at risk. Cancer Letters, 538, 215709. https://doi.org/10.1016/j.canlet.2022.215709

Biermann, J., Melms, J. C., Amin, A. D., Wang, Y., Caprio, L. A., Karz, A., Tagore, S., Barrera, I., Ibarra-Arellano, M. A., Andreatta, M., Fullerton, B. T., Gretarsson, K. H., Sahu, V., Mangipudy, V. S., Nguyen, T. T. T., Nair, A., Rogava, M., Ho, P., Koch, P. D., … Izar, B. (2022). Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. Cell, 185(14), 2591-2608.e30. https://doi.org/10.1016/j.cell.2022.06.007

Plascak, J. J., Beyer, K., Xu, X., Stroup, A. M., Jacob, G., & Llanos, A. A. M. (2022). Association Between Residence in Historically Redlined Districts Indicative of Structural Racism and Racial and Ethnic Disparities in Breast Cancer Outcomes. JAMA Network Open, 5(7), e2220908. https://doi.org/10.1001/jamanetworkopen.2022.20908

Thomas, A. S., Huang, Y., Kwon, W., Schrope, B. A., Sugahara, K., Chabot, J. A., Wright, J. D., & Kluger, M. D. (2022). Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy. Journal of Gastrointestinal Surgery, 26(7), 1425–1435. https://doi.org/10.1007/s11605-022-05302-3

McGuinness, J. E., Ro, V., Mutasa, S., Pan, S., Hu, J., Trivedi, M. S., Accordino, M. K., Kalinsky, K., Hershman, D. L., Ha, R. S., & Crew, K. D. (2022). Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer. Breast Cancer Research and Treatment, 194(1), 35–47. https://doi.org/10.1007/s10549-022-06614-3

Li, W., & Shen, M. M. (2022). Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models. Seminars in Cancer Biology, 82, 60–67. https://doi.org/10.1016/j.semcancer.2021.06.016

Rustgi, S. D., Zylberberg, H. M., & Hur, C. (2022). Databases for Gastrointestinal Clinical and Public Health Research: Have Database, Will Research. Gastroenterology, 163(1), 31–34. https://doi.org/10.1053/j.gastro.2022.04.024

Lemus, O. M. D., Wang, Y., Li, F., Jambawalikar, S., Horowitz, D. P., Xu, Y., & Wuu, C. (2022). Dosimetric assessment of patient dose calculation on a deep learning‐based synthesized computed tomography image for adaptive radiotherapy. Journal of Applied Clinical Medical Physics, 23(7). Portico. https://doi.org/10.1002/acm2.13595

Park, J., Artin, M. G., Lee, K. E., Pumpalova, Y. S., Ingram, M. A., May, B. L., Park, M., Hur, C., & Tatonetti, N. P. (2022). Deep learning on time series laboratory test results from electronic health records for early detection of pancreatic cancer. Journal of Biomedical Informatics, 131, 104095. https://doi.org/10.1016/j.jbi.2022.104095

Tremblay, D., Srisuwananukorn, A., Ronner, L., Podoltsev, N., Gotlib, J., Heaney, M. L., Kuykendall, A., O’Connell, C. L., Shammo, J. M., Fleischman, A., Mesa, R., Yacoub, A., Hoffman, R., Moshier, E., Zubizarreta, N., & Mascarenhas, J. (2022). European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera. HemaSphere, 6(6), e721. https://doi.org/10.1097/hs9.0000000000000721

Lassman, A. B., Sepúlveda-Sánchez, J. M., Cloughesy, T. F., Gil-Gil, M. J., Puduvalli, V. K., Raizer, J. J., De Vos, F. Y. F., Wen, P. Y., Butowski, N. A., Clement, P. M. J., Groves, M. D., Belda-Iniesta, C., Giglio, P., Soifer, H. S., Rowsey, S., Xu, C., Avogadri, F., Wei, G., Moran, S., & Roth, P. (2022). Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clinical Cancer Research, 28(11), 2270–2277. https://doi.org/10.1158/1078-0432.ccr-21-2664

Meng, Z., Li, F.-L., Fang, C., Yeoman, B., Qiu, Y., Wang, Y., Cai, X., Lin, K. C., Yang, D., Luo, M., Fu, V., Ma, X., Diao, Y., Giancotti, F. G., Ren, B., Engler, A. J., & Guan, K.-L. (2022). The Hippo pathway mediates Semaphorin signaling. Science Advances, 8(21). https://doi.org/10.1126/sciadv.abl9806